Lerisetron

CAS No. 143257-98-1

Lerisetron ( —— )

Catalog No. M21941 CAS No. 143257-98-1

Lerisetron is an antagonist of serotonin type 3 (5-HT3) receptor, with antiemetic activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 88 In Stock
5MG 138 In Stock
10MG 209 In Stock
25MG 370 In Stock
50MG 537 In Stock
100MG 781 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Lerisetron
  • Note
    Research use only, not for human use.
  • Brief Description
    Lerisetron is an antagonist of serotonin type 3 (5-HT3) receptor, with antiemetic activity.
  • Description
    Lerisetron is an antagonist of serotonin type 3 (5-HT3) receptor, with antiemetic activity.showed a decrease in total clearance and distribution volume of the central compartment in old rats. The lerisetron free (unbound) fraction remained unchanged among the groups, and there were no significant differences in alpha(1)-acid glycoprotein levels. The concentration-effect relationship was best described by a sigmoid E(max) model. Since the drug concentration in plasma at half-maximal effect (EC(50)) decreased in old rats, an increased sensitivity to the effect of lerisetron in old animals could be expected.
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    143257-98-1
  • Formula Weight
    292.38
  • Molecular Formula
    C18H20N4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:53 mg/ml(181.27 mM)
  • SMILES
    C(c1ccccc1)n1c(nc2ccccc12)N1CCNCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Nerea, Jauregizar, Antonio, et al. Age-Related Changes in Pharmacokinetics and Pharmacodynamics of Lerisetron in the Rat: A Population Pharmacokinetic Model[J]. Gerontology, 2003 2. Strenge H , Goebel S , Kowalski J , et al. Effects of Lerisetron, a New 5-HT3 Receptor Antagonist, on Ipecacuanha- induced Emesis in Healthy Volunteers[J]. Arzneimittelforschung, 2002, 52(09):689-694.
molnova catalog
related products
  • GSK-812

    GSK-812 is a potent neuroprotectant that can induce GDNF in normal and diseased retina.

  • GR 125743

    GR 125743 is a novel antagonist of 5-HT1B/1D receptor.GR-125743, a new radiolabelled derivative of a compound that exhibits selective antagonistic properties with respect to the serotonin human (h5-HT1D) and human (h5-HT1B) receptors.?The compound has been characterized for its ability to label the cloned h5-HT1D and h5-HT1B receptors.?

  • Haloperidol

    Haloperidol has been found to be highlt potent neuroleptic by relieving nervous through the depression of nerve function.